0
Signin
countryflagCA

888-969-2592

RY 173.53 0.0461% SHOP 159.5 1.56% TD 76.22 0.8068% ENB 60.09 0.0333% BN 82.79 0.988% TRI 234.13 -0.1706% CNQ 43.47 0.6949% CP 105.63 0.4756% CNR 148.07 0.5637% BMO 139.11 -0.2152% BNS 77.03 -0.0649% CSU 4547.4502 0.8243% CM 92.53 0.2383% MFC 44.05 0.0454% ATD 80.59 0.1989% NGT 54.92 0.1459% TRP 66.54 0.2561% SU 50.61 0.4765% WCN 248.6 1.1885% L 191.07 -0.4325%

Avricore Health Inc

Healthcare CA AVCR

0.06CAD
-(-%)

Last update at 2024-12-24T17:18:00Z

Day Range

0.060.06
LowHigh

52 Week Range

0.100.34
LowHigh

Fundamentals

  • Previous Close 0.06
  • Market Cap14.48M
  • Volume14100
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA0.52M
  • Revenue TTM4.48M
  • Revenue Per Share TTM0.04
  • Gross Profit TTM 0.03M
  • Diluted EPS TTM-

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -0.70122M -0.81823M -1.70813M -1.17397M -1.91625M
Minority interest - - - - -
Net income -0.70122M -0.81823M -1.70813M -1.17397M -2.10561M
Selling general administrative 1.84M 1.01M 1.71M 0.85M 1.30M
Selling and marketing expenses - 0.18M - 0.00228M 0.04M
Gross profit 1.20M 0.46M 0.03M 0.02M 0.01M
Reconciled depreciation 0.42M 0.18M 0.02M 0.07M 0.18M
Ebit - -0.80986M -1.74501M -0.97767M -1.60050M
Ebitda - -0.62681M -1.72702M -0.85915M -1.42003M
Depreciation and amortization - 0.18M 0.02M 0.12M 0.18M
Non operating income net other - - - - -
Operating income -0.68724M -0.80986M -1.74501M -0.85915M -1.60050M
Other operating expenses - 2.58M 1.86M 0.89M 1.63M
Interest expense 0.00000M 0.00542M 0.04M 0.16M 0.00514M
Tax provision - - - - -
Interest income 0.00328M 0.00809M 0.00058M 0.00000M 0.00040M
Net interest income -0.00272M 0.00266M -0.04466M -0.16486M -0.01065M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - 0.04M 0.04M 0.20M
Total revenue 3.49M 1.77M 0.12M 0.03M 0.03M
Total operating expenses 4.17M 1.27M 1.77M 0.87M 1.61M
Cost of revenue 2.28M 1.31M 0.09M 0.02M 0.02M
Total other income expense net -0.01125M -0.00837M 0.08M -0.15586M -0.30851M
Discontinued operations - - - - -0.18936M
Net income from continuing ops -0.70122M -0.81823M -1.70813M -1.17397M -1.91625M
Net income applicable to common shares - - -1.70813M -1.17397M -2.10561M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 2.54M 2.57M 2.28M 0.44M 0.21M
Intangible assets 0.05M 0.03M 0.03M 0.00000M 0.00000M
Earning assets - - - - -
Other current assets - - 0.01M 0.06M 0.02M
Total liab 0.53M 0.60M 0.08M 1.15M 0.67M
Total stockholder equity 2.01M 1.96M 2.20M -0.71404M -0.46545M
Deferred long term liab - - - - -
Other current liab - - - - -
Common stock - - 26.62M 22.29M 21.40M
Capital stock 27.19M 27.06M 26.62M 22.29M 21.40M
Retained earnings -31.73556M -31.03434M -30.21612M -28.50799M -27.33402M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.28M 0.62M 2.01M 0.30M 0.01M
Cash and equivalents - - - - -
Total current liabilities 0.53M 0.60M 0.08M 1.15M 0.67M
Current deferred revenue - - - - -
Net debt - - - 0.70M -
Short term debt - - - - -
Short long term debt 0.04M 0.04M 0.04M 1.00M -
Short long term debt total - - - - -
Other stockholder equity - - 5.79M 5.51M 5.47M
Property plant equipment - - 0.09M - -
Total current assets 0.77M 1.43M 2.16M 0.44M 0.21M
Long term investments - - - - -
Net tangible assets - - 2.17M -0.71404M -0.46545M
Short term investments 0.01000M 0.01000M - - -
Net receivables 0.42M 0.75M 0.09M 0.01M 0.02M
Long term debt - - - - -
Inventory 0.02M - - - 0.00000M
Accounts payable 0.43M 0.26M 0.04M 0.13M 0.63M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - 0.00000M
Deferred long term asset charges - - - - -
Non current assets total 1.76M 1.14M 0.12M 0.00000M 0.00000M
Capital lease obligations - - - 0.00000M 0.02M
Long term debt total - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -1.04686M -1.20852M -0.14036M -0.00430M 0.00000M
Change to liabilities - - -0.06959M -0.33904M 0.36M
Total cashflows from investing activities - - -0.14036M -0.14036M -0.14036M
Net borrowings - - -1.00000M 0.93M -0.05201M
Total cash from financing activities 0.04M 0.25M 3.08M 1.51M 0.62M
Change to operating activities - - 0.07M 0.05M 0.11M
Net income -0.70122M -0.81823M -1.70813M -1.17397M -1.91625M
Change in cash -0.34396M -1.39247M 1.71M 0.29M -0.07064M
Begin period cash flow 0.62M 2.01M 0.30M 0.01M 0.08M
End period cash flow 0.28M 0.62M 2.01M 0.30M 0.01M
Total cash from operating activities 0.66M -0.43783M -1.23415M -1.22340M -0.68641M
Issuance of capital stock 0.00000M 0.00000M 2.40M 0.63M 0.64M
Depreciation 0.42M 0.18M 0.02M 0.01M 0.18M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory -0.02068M -0.26842M 0.07M -0.18043M -0.18043M
Change to account receivables 0.34M -0.68749M -0.07962M 0.00355M 0.00355M
Sale purchase of stock - - - - -
Other cashflows from financing activities - 0.25M 1.68M 0.90M 0.03M
Change to netincome - - 0.53M 0.42M 0.76M
Capital expenditures 1.05M 1.20M 0.14M 0.11M 0.11M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.23M -0.14284M -0.07823M -0.47067M 0.47M
Stock based compensation 0.70M 0.33M 0.50M 0.13M 0.09M
Other non cash items -0.00000M 0.00867M 0.04M 0.29M 0.00514M
Free cash flow -0.38646M -1.63635M -1.37452M -1.22340M -0.68641M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AVCR
Avricore Health Inc		 - -% 0.06 - - 3.12 6.14 3.07 29.38
TELO
Telo Genomics Corp		 - -% 0.12 - - - 16.43 -6.3236
JUMP
Leveljump Healthcare Corp		 - -% 0.05 - - 0.41 0.79 0.78 -7.3813

Reports Covered

Stock Research & News

View All

Profile

Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. It provides HealthTab, a turnkey point-of-care testing platform that turns pharmacies into community point-of-care diagnostic centers. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.

Avricore Health Inc

789 West Pender Street, Vancouver, BC, Canada, V6C 1H2

Key Executives

Name Title Year Born
Mr. Hector Bremner CEO & Director 1982
Ms. Kiriaki Smith CPA, CFO, CGA, CPA CFO & Corp. Sec. 1967
Mr. Rodger Seccombe Head of Healthtab Division & Director 1981
Mr. Will Seccombe Communications Advisor NA
Dr. Allan Shapiro Mang. of Bus. Devel. NA
Ms. Kiriaki Smith CPA, CFO, CGA, CPA CFO & Corporate Secretary 1967
Mr. Rodger Seccombe CTO & Director 1981

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.